abstract |
The present invention relates to liquid pharmaceutical compositions comprising steroidal drugs, such as drospirenone, in molecularly dispersed form. The compositions are adapted for oral administration and preferably to be absorbed from the gastro-intestinal tract. Such compositions are found to have high bioavailability, good chemical stability, and fast in-vitro dissolution release and can be produced under conditions, which do not require costly equipment or safety guards. |